Direct costs of rheumatoid arthritis (RA) in Portugal: The cesar study results

被引:0
|
作者
Branco, JC [1 ]
机构
[1] Hosp Egas Moniz, Unidade Reumatol, Lisbon, Portugal
关键词
D O I
暂无
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
引用
收藏
页码:533 / 533
页数:1
相关论文
共 50 条
  • [41] IMMUNOSEROLOGY OF RHEUMATOID ARTHRITIS (RA)
    MATHEWS, RS
    LINCOLN, CR
    BUCKLEY, CE
    ARTHRITIS AND RHEUMATISM, 1967, 10 (03): : 297 - &
  • [42] Vasculitis in rheumatoid arthritis/RA/
    Yakovliev, P. H.
    Popov, I. K.
    ALLERGY, 2017, 72 : 756 - 756
  • [43] TOCILIZUMAB IN RHEUMATOID ARTHRITIS (RA): LITHE 2-YEAR RESULTS
    Burgos-Vargas, R.
    Fleischmann, R.
    Pinheiro, Castelar G.
    Andrade, L.
    Irazoque, F.
    Kissel, F.
    Alecock, E.
    Kremer, J.
    JCR-JOURNAL OF CLINICAL RHEUMATOLOGY, 2010, 16 (03) : S32 - S33
  • [44] Direct and indirect costs of rheumatoid arthritis and the socio-emotional effects of this disease an Austrian study
    Wagner, Ernst
    Lackerbauer, Eva
    Siegmeth, Walter
    WIENER MEDIZINISCHE WOCHENSCHRIFT, 2005, 155 (9-10) : 217 - 226
  • [45] Direct and indirect medical costs incurred by Canadian patients with rheumatoid arthritis: A 12 year study
    Clarke, AE
    Zowall, H
    Levinton, C
    Assimakopoulos, H
    Sibley, JT
    Haga, M
    Shiroky, J
    Neville, C
    Lubeck, DP
    Grover, SA
    Esdaile, JM
    JOURNAL OF RHEUMATOLOGY, 1997, 24 (06) : 1051 - 1060
  • [46] SOCIETAL COST OF RHEUMATOID ARTHRITIS (RA) IN THE UNITED STATES: METHODOLOGY FOR INCORPORATING INTANGIBLE COSTS
    Birnbaum, H.
    Pike, C.
    Kaufman, R.
    Marynchenko, M.
    Kidolezi, Y.
    Cifaldi, M.
    VALUE IN HEALTH, 2009, 12 (03) : A16 - A17
  • [47] Costs and predictors of costs in rheumatoid arthritis:: A prevalence-based study
    Lajas, C
    Abasolo, L
    Bellajdel, B
    Hernández-García, C
    Carmona, L
    Vargas, E
    Lázaro, P
    Jover, JA
    ARTHRITIS & RHEUMATISM-ARTHRITIS CARE & RESEARCH, 2003, 49 (01): : 64 - 70
  • [48] Resource utilization and costs of severe rheumatoid arthritis (RA) from societal and patient perspectives
    de Putte, L. B. A. Van
    Dietz, B. M.
    Raschke, U.
    Kupper, H.
    Cifaldi, M. A.
    Reitberger, U.
    Sterz, R.
    ANNALS OF THE RHEUMATIC DISEASES, 2006, 65 : 604 - 604
  • [49] RHEUMATOID ARTHRITIS (RA) TREATMENT COSTS AMONG US PATIENTS TREATED WITH INFUSED BIOLOGICS
    Ogale, S.
    Henk, H. J.
    VALUE IN HEALTH, 2010, 13 (03) : A125 - A126
  • [50] Direct cost of patients on TNF-α inhibitors for the treatment of rheumatoid arthritis (RA).
    Kerney, D
    Ollendorf, D
    Yu, EB
    Woolley, JM
    ARTHRITIS AND RHEUMATISM, 2004, 50 (09): : S509 - S509